CyVek Receives $5,500,000 Series D Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d14e0301-93f9-425b-b513-b4cbbeeb06d8&Preview=1 -
Date
2/4/2013 -
Company Name
CyVek -
Mailing Address
2 Barnes Industrial Road South Wallingford, CT 06492 -
Company Description
The objective of the CyVek technology is to provide a robust platform for multiplexed proteomics, particularly to serve the market needs of biomarker validation. -
Website
http://www.cyvek.com -
Transaction Type
Venture Equity -
Transaction Amount
$5,500,000 -
Transaction Round
Series D -
Proceeds Purposes
The Series D funding enables the company to create the infrastructure needed to commercialize its novel immunoassay technology, CyPlex(TM), an integrated test system which includes a proprietary microfluidic cartridge that allows the analysis of multiple biomarkers from very small amounts of biological samples. -
M&A Terms
-
Venture Investor
Connecticut Innovations -
Venture Investor
Undisclosed
